Search
for
Sort by
Research 30 of 1000+
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Prostaglandins and Skin Cancer: An Old Pathway With New Insights in Cutaneous Oncology
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014
- Correspondence
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Cutaneous toxicities of new treatments for melanoma
- Cutaneous adverse effects of targeted therapies
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Pleomorphic Appearance of Breast Cancer Cutaneous Metastases
- P164 Cutaneous toxicities occurring during amivantamab treatment: the experience of a single large specialist institution
- Editorial
- Cutaneous Reactions to Chemotherapeutic Agents
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Incidence and management of cutaneous toxicities associated with cetuximab
- The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- Cutaneous toxicities of cancer therapy
- The dermatology consultant: A retrospective analysis of inpatient dermatology
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects